Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

Presenter: Bernard J. Gersh, Michel Ovize

October 31, 2017

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

CASE 2- Image Guided Intervention in Traumatic Dissection of Dominant Right Coronary Artery Presenting as Acute Myocardial Infarction

Presenter: Pedro de Araujo Goncalves, Rabin dra Nath Chakraborty

October 30, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

More Liberal Definition of Type 2 MI May Misclassify Some Patients

Todd Neale

September 20, 2017

Presentation ESC 2017

Validation of the European Society of Cardiology 0/1-Hour Algorithm for Rule-out and Rule-in of Acute Myocardial Infarction

Presenter: Raphael Twerenbold

September 08, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

Advertisement

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

CASE 2- Image Guided Intervention in Traumatic Dissection of Dominant Right Coronary Artery Presenting as Acute Myocardial Infarction

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

New Performance and Quality Metrics for STEMI and NSTEMI Care

More Liberal Definition of Type 2 MI May Misclassify Some Patients

Validation of the European Society of Cardiology 0/1-Hour Algorithm for Rule-out and Rule-in of Acute Myocardial Infarction

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content